Mankind Pharma Shares Surge 9% After Strong Q2 Results
Shares extended gains for a second consecutive session on Tuesday after the company’s Q2 FY27 earnings. Brokerages differed on the stock outlook, with Kotak Institutional Equities bullish and Bernstein cautious.